EMB vs IBB
iShares JP Morgan USD Emerging Markets Bond ETF vs iShares Biotechnology ETF
- • EMB has the lower expense ratio at 0.39% vs 0.44% for IBB.
- • EMB pays a higher dividend yield (5.37%).
Side-by-side metrics
| Metric | EMB | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.39% | 0.44% |
Dividend yield Trailing 12-month yield. | 5.37% | 0.16% |
AUM Assets under management — bigger funds are typically more liquid. | $13.57B | $11.50B |
YTD return | 0.44% | 30.22% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.06 | 0.60 |
P/E ratio | — | 25.48 |
Last price | $92.06 | $217.75 |
Inception | — | — |
Issuer | iShares | iShares |
EMB top holdings
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 0.50% |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
About EMB
EMB (iShares JP Morgan USD Emerging Markets Bond ETF) is USD-denominated emerging market government bonds. Managed by iShares, the fund carries $13.6B in assets under management, an expense ratio of 0.39%, a dividend yield of 5.37%. Its largest holding is BlackRock Cash Funds Treasury SL Agency (XTSLA), which represents 0.5% of the portfolio.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.